Ipamorelin, a new growth hormone-releasing peptide, induces longitudinal bone growth in rats
1 Introduction Autoimmune diseases (ADs) arise from the immune systems aberrant response against self-tissues, encompassing diverse conditions such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), inflammatory bowel disease (IBD), type 1 diabetes (T1D), and primary biliary cholangitis (PBC) ( Mounting evidence suggests that gut microbiota and its metabolites play a key role in host health and diverse diseases, such as obesity, depression, sclerosis, kidney disease, and dialysis ( At present, in the interest of reshaping the disordered intestinal immune activity in the disease state and alleviating the disease, people propose a series of flora-related immunotherapies based on the close interaction between the intestinal immune system and the flora (34)
While some peptides like semaglutide (a GLP-1 receptor agonist) have FDA approval for weight loss, others are available only through off-label use or experimental stages
Found in every cell, it is composed of three amino acids: cysteine, glycine and glutamic acid
JAMA 282 , 15681575 (1999)
